GCM
NPCE icon

Graham Capital Management’s Neuropace NPCE Stock Holding History

Graham Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,065
Closed -$146K – 1517
2025
Q2 		$146K Buy
+13,065
New +$163K ﹤0.01% 1172

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Graham Capital Management's NPCE Position: Q3 2025 in Review

Graham Capital Management sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 13,065 shares — an estimated $146K sold.

Graham Capital Management first reported a position in NPCE in Q2 2025 and held it in 1 quarter. The position peaked at $146K in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

  • Graham Capital Management reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
  • Graham Capital Management sold 13,065 Neuropace shares in Q3 2025, an estimated $146K.
  • Graham Capital Management first reported a position in Neuropace in Q2 2025 and held it in 1 quarter.
  • Graham Capital Management's Neuropace position peaked at $146K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.